Barry V L Potter Selected Research

2-O-benzylinositol 1,3,4,5,6-pentakisphosphate

1/2016

A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barry V L Potter Research Topics

Disease

45	Breast Neoplasms (Breast Cancer) 06/2022 - 12/2002
36	Neoplasms (Cancer) 01/2020 - 02/2003
10	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 02/2003
5	Obesity 05/2012 - 03/2006
4	Endometriosis 01/2021 - 09/2015
4	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 08/2008
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2011 - 05/2007
3	Autoimmune Diseases (Autoimmune Disease) 11/2018 - 06/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2011 - 03/2009
3	Type 2 Diabetes Mellitus (MODY) 05/2007 - 03/2006
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 02/2003
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2018 - 07/2010
2	Cardiac Arrhythmias (Arrythmia) 11/2018 - 06/2015
2	Multiple Sclerosis 11/2018 - 07/2010
2	Carcinoma (Carcinomatosis) 01/2016 - 09/2005
2	Neoplasm Metastasis (Metastasis) 01/2016 - 03/2004
2	Infections 02/2014 - 01/2014
2	Hyperplasia 02/2013 - 03/2009
2	Lymphoma (Lymphomas) 07/2009 - 06/2009
2	Metabolic Diseases (Metabolic Disease) 05/2007 - 03/2006
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2022
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2019
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 11/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Inflammation (Inflammations) 01/2019
1	Vascular System Injuries 01/2019
1	Opsismodysplasia 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Neurofibrosarcoma (MPNST) 10/2015
1	Hypoxia (Hypoxemia) 10/2015
1	Virus Diseases (Viral Diseases) 02/2014
1	Multiple Myeloma 01/2014
1	Dyslipidemias (Dyslipidemia) 08/2011

Drug/Important Bio-Agent (IBA)

39	Hormones (Hormone)IBA 01/2020 - 02/2003
28	Steryl-Sulfatase (Steroid Sulfatase)IBA 01/2020 - 12/2002
15	EnzymesIBA 01/2021 - 07/2003
12	Pharmaceutical PreparationsIBA 01/2020 - 02/2003
11	sulfamic acid (ammonium sulfamate)IBA 06/2022 - 02/2005
11	Aromatase (CYP19)IBA 10/2015 - 05/2005
9	2- methoxyestradiol- 3,17- O,O- bis(sulfamate)IBA 10/2015 - 01/2006
7	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 04/2006
7	irosustatIBA 01/2018 - 03/2006
7	2-MethoxyestradiolIBA 10/2015 - 02/2003
6	SteroidsIBA 04/2014 - 03/2006
5	Estrogens (Estrogen)FDA Link 01/2021 - 07/2003
5	SulfatasesIBA 08/2011 - 09/2006
5	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 07/2010 - 03/2006
4	Testosterone (Sustanon)FDA Link 11/2021 - 03/2009
4	NAADP (nicotinic acid adenine dinucleotide phosphate)IBA 11/2018 - 06/2009
4	Sulfates (Sulfates, Inorganic)IBA 07/2011 - 03/2006
4	Messenger RNA (mRNA)IBA 05/2008 - 03/2006
3	Estrone FDA Link 01/2021 - 07/2003
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2008
3	Phosphotransferases (Kinase)IBA 02/2014 - 03/2004
3	Oxidoreductases (Dehydrogenase)IBA 02/2013 - 01/2006
3	Androstenedione (4 Androstene 3,17 dione)IBA 02/2013 - 10/2008
3	GlucocorticoidsIBA 09/2011 - 03/2009
3	STX 213IBA 09/2008 - 09/2006
2	1,2,3,4-tetrahydroisoquinolineIBA 06/2022 - 02/2014
2	taxaneIBA 01/2019 - 01/2008
2	ProdrugsIBA 01/2018 - 09/2015
2	Inositol (Myoinositol)IBA 01/2016 - 02/2014
2	Androgen Receptors (Androgen Receptor)IBA 02/2013 - 03/2009
2	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2011 - 05/2007
2	Estrogen ReceptorsIBA 10/2008 - 04/2007
2	2- methoxyestradiol- 3,17- bis- O,O- sulfamateIBA 09/2008 - 02/2003
2	Aromatase InhibitorsIBA 04/2008 - 02/2005
2	inositol-1,3,4,5,6-pentakisphosphateIBA 09/2005 - 03/2004
1	ElementsIBA 06/2022
1	benzylamineIBA 11/2021
1	Neurofibromin 2 (Merlin)IBA 11/2019
1	Neurofibromin 1 (Neurofibromin)IBA 11/2019
1	inositol pentaphosphate (inositol pentakisphosphate)IBA 01/2019
1	Carbonic Anhydrase IXIBA 01/2019
1	CationsIBA 01/2019
1	Fibrinogen (Factor I)FDA Link 01/2019
1	Inositol PhosphatesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Transient Receptor Potential ChannelsIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2017
1	scyllitol (scyllo-inositol)IBA 01/2016
1	Phospholipases (Phospholipase)IBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	2-O-benzylinositol 1,3,4,5,6-pentakisphosphateIBA 01/2016
1	Progesterone FDA LinkGeneric 10/2015
1	estrone-3-O-sulfamateIBA 10/2015
1	2-ethyloestradiol-bis-sulfamateIBA 10/2015
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2015
1	Diphosphates (Pyrophosphates)IBA 02/2014
1	InterferonsIBA 02/2014
1	7- methoxy- 2- (3- methoxybenzyl)- 6- sulfamoyloxy- 1,2,3,4- tetrahydroisoquinolineIBA 02/2014
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2014
1	1- acetyl- 5- (2- (4- chlorophenoxy)phenylamino)- 2,3,4,5- tetrahydrobenzo(b)azepineIBA 02/2013
1	AndrogensIBA 02/2013
1	Cortisone FDA Link 08/2011
1	AndrostenediolIBA 07/2011
1	EstersIBA 04/2010
1	Caspase 3 (Caspase-3)IBA 10/2009

Therapy/Procedure

12	Therapeutics 11/2021 - 12/2002
2	Injections 10/2008 - 09/2006